ArticleAnais brasileiros de dermatologia

Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon.

Vladimir Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.